Onconetix Provides Additional $500,000 Bridge Financing to Realbotix LLC
Onconetix, Inc. announced an additional $500,000 advance to Realbotix LLC under the strategic bridge financing facility (Grid Note), bringing total principal outstanding to $3,000,000 out of a maximum $5,000,000 facility. The Grid Note is non-interest bearing prior to closing of the pending acquisition and will be automatically cancelled and discharged in full upon closing, with the cash required at closing reduced by total principal advanced plus an additional $500,000. If the Share Exchange Agreement is termin...
Key takeaways
Onconetix made an additional $500,000 advance to Realbotix LLC under the Grid Note bridge financing facility.
Total drawn under the facility now stands at $3,000,000 out of the $5,000,000 aggregate loan commitment.
The Grid Note is non-interest bearing prior to closing of the pending acquisition.
Upon closing of the acquisition, the Grid Note and all obligations will be automatically cancelled and discharged in full.
The cash required at closing will be reduced by the total principal advanced plus an additional $500,000.
If the Share Exchange Agreement is terminated, interest accrues at 12% per annum from the date of termination.
The pending acquisition, announced February 12, 2026, is an all-stock transaction for 100% of Realbotix LLC equity interests.
Key metrics
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open Investor relationsFollow ONCO in real time
Get material earnings, filing, IR, and earnings-call alerts by email.